Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Open
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverINGN
HealthcareNMSUSD

Inogen, Inc.

$00123456789.0012345678900123456789+3.4%
52w low (est.) $4.84$8.26 52w high (est.)
Market data · updated 4m ago
Market data
Market cap
USD173.28M
52w range
USD5.34 - USD9.13
Beta
1.59
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD6.68
Margin of safety
+5.0%
Quality & efficiency
Moat score
29/100
Return on equity
-13.1%
Profit margin
-7.1%
Debt / equity
0.09
Growth & analysts
Revenue growth
+3.4%
Analyst target
USD12.67
Target upside
+99.2%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Inogen, Inc.

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

Valuation

ValueGrowthProfitHealthIncome34QUALITY
Overall Rating
37
Reduce
Reduce

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score29
DCF Intrinsic Value
USD6.68+5.0% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD173.28M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+3.4%
Profit Margin
-7.1%
ROE
-13.1%
Debt / Equity
0.09
Beta
1.59
vs Healthcare sector:Moat 29 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · INGN